logo

For the Inventor, By the Inventor

Aichi, Japan

Genesis Research Institute, Incorporated

Calculating rank
USPTO Granted Patents = 21

% Expired Patents = 42.9



Forward Citations = 79

Loading Chart...
Loading Chart...

30 inventors (with patents filed for the assignee):

goldMedal Yoshihiro Takeda (10 out of 11 patents)

silverMedal Namiki Toyama (6 out of 6 patents)

bronzeMedal Kazuhiro Egashira (6 out of 6 patents)

4.  Toshiaki Tanaka (6 out of 89 patents)

5.  Seitoku Ito (6 out of 13 patents)

6.  Masahiko Ichihashi (4 out of 4 patents)

7.  Fumitaka Mafune (4 out of 4 patents)

8.  Takunori Taira (3 out of 28 patents)

9.  Jun Akiyama (3 out of 3 patents)

10.  Shigeo Asai (3 out of 8 patents)

11.  Hitoshi Kasai (2 out of 8 patents)

12.  Yoshitaka Koseki (2 out of 2 patents)

13.  Takaaki Kamishima (2 out of 2 patents)

14.  Tamotsu Kondou (2 out of 2 patents)

15.  Kunihiko Hara (2 out of 31 patents)


21 patents:

1. 12128383 - Cluster supported catalyst and production method therefor (2024-10-29),
2. 11998896 - Cluster supported catalyst and production method therefor (2024-06-04),
3. 11673126 - Cluster-supporting porous carrier and method for producing same (2023-06-13),
4. 11480697 - Earthquake prediction method and earthquake prediction system (2022-10-25),
5. 11407772 - Optically-active cyclopentenone derivatives (2022-08-09),
6. 11219884 - Cluster supported catalyst and production method therefor (2022-01-11),
7. 11014865 - Production method for cyclopentenone derivative (2021-05-25),
8. 11014073 - Cluster supported catalyst and method for producing same (2021-05-25),
9. 10576460 - Cluster-supporting catalyst and process for producing the same (2020-03-03),
10. 9707514 - Nitric oxide reducing catalyst, method for reducing nitric oxide, method for producing nitrogen, method for treating nitric oxide and carbon monoxide (2017-07-18),
11. 9493817 - Decomposition method and decomposition apparatus for nucleic acid polymer (2016-11-15),
12. 9384888 - Transparent polycrystalline material and production process for the same (2016-07-05),
13. 9188738 - Translucent polycrystalline material and manufacturing method thereof (2015-11-17),
14. 9109297 - Method for production of accumulated product of nano-substance, accumulated product of nano-substance, device comprising the accumulated product, and method for analysis of structure of nano-substance (2015-08-18),
15. 8986510 - Method of decomposing target and decomposition apparatus (2015-03-24),
Company Overview
Genesis Research Institute, Incorporated is a prominent entity based in Aichi, Japan, specializing in advanced research and development across various scientific domains. The organization focuses on innovative solutions in biotechnology and pharmaceuticals, aiming to enhance healthcare outcomes through cutting-edge technologies. With a commitment to scientific excellence, Genesis Research Institute collaborates with academic and industry partners to drive forward-thinking research initiatives that address critical challenges in health and medicine.
Profile summary synthesized from public USPTO records and patent filings.

logo

Company Badge

USPTO Data Jan 1 1976 - Oct 20 2026

21 Patents

#61 in Aichi

#2,866 in Japan

#30,001 in the World

Aichi, JP
Aichi, Japan

Genesis Research Institute, Incorporated

Forward Citations = 79

30 inventors:

goldMedal Yoshihiro Takeda (10 out of 11 patents)

silverMedal Namiki Toyama (6 out of 6 patents)

bronzeMedal Kazuhiro Egashira (6 out of 6 patents)

4.  Toshiaki Tanaka (6 out of 89 patents)

5.  Seitoku Ito (6 out of 13 patents)

IDiyas Innovation Intelligence. (2026). Company Patent Portfolio: Genesis Research Institute, Incorporated. Retrieved from https://idiyas.com/company/genesis-research-institute

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…